325 related articles for article (PubMed ID: 16862806)
41. [Observations on Acanthamoeba trophozoites in axenic cultures and their staining characteristics with different stains].
Polat ZA; Ozçelik S; Vural A; Saygi G
Turkiye Parazitol Derg; 2007; 31(1):7-13. PubMed ID: 17471404
[TBL] [Abstract][Full Text] [Related]
42. Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba.
Padzik M; Hendiger EB; Chomicz L; Grodzik M; Szmidt M; Grobelny J; Lorenzo-Morales J
Parasitol Res; 2018 Nov; 117(11):3519-3525. PubMed ID: 30112674
[TBL] [Abstract][Full Text] [Related]
43. Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.
Walochnik J; Duchêne M; Seifert K; Obwaller A; Hottkowitz T; Wiedermann G; Eibl H; Aspöck H
Antimicrob Agents Chemother; 2002 Mar; 46(3):695-701. PubMed ID: 11850250
[TBL] [Abstract][Full Text] [Related]
44. Area 51: How do Acanthamoeba invade the central nervous system?
Siddiqui R; Emes R; Elsheikha H; Khan NA
Trends Parasitol; 2011 May; 27(5):185-9. PubMed ID: 21507718
[TBL] [Abstract][Full Text] [Related]
45. Amoebicidal activity of phytosynthesized silver nanoparticles and their in vitro cytotoxicity to human cells.
Borase HP; Patil CD; Sauter IP; Rott MB; Patil SV
FEMS Microbiol Lett; 2013 Aug; 345(2):127-31. PubMed ID: 23746354
[TBL] [Abstract][Full Text] [Related]
46. Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid.
Petry F; Torzewski M; Bohl J; Wilhelm-Schwenkmezger T; Scheid P; Walochnik J; Michel R; Zöller L; Werhahn KJ; Bhakdi S; Lackner KJ
J Clin Microbiol; 2006 May; 44(5):1903-4. PubMed ID: 16672436
[TBL] [Abstract][Full Text] [Related]
47. Amebae and ciliated protozoa as causal agents of waterborne zoonotic disease.
Schuster FL; Visvesvara GS
Vet Parasitol; 2004 Dec; 126(1-2):91-120. PubMed ID: 15567581
[TBL] [Abstract][Full Text] [Related]
48. Correlation of radical-scavenging capacity and amoebicidal activity of Matricaria recutita L. (Asteraceae).
Hajaji S; Sifaoui I; López-Arencibia A; Reyes-Batlle M; Jiménez IA; Bazzocchi IL; Valladares B; Pinero JE; Lorenzo-Morales J; Akkari H
Exp Parasitol; 2017 Dec; 183():212-217. PubMed ID: 28919332
[TBL] [Abstract][Full Text] [Related]
49. Acanthamoeba infection in an interhemispheric ependymal cyst: a case report.
Ranjan R; Handa A; Choudhary A; Kumar S
Surg Neurol; 2009 Aug; 72(2):185-9. PubMed ID: 18617243
[TBL] [Abstract][Full Text] [Related]
50. Acanthamoeba invasion of the central nervous system.
Khan NA
Int J Parasitol; 2007 Feb; 37(2):131-8. PubMed ID: 17207487
[TBL] [Abstract][Full Text] [Related]
51. Disseminated acanthamoeba infection in a renal transplant recipient: a case report.
Mutreja D; Jalpota Y; Madan R; Tewari V
Indian J Pathol Microbiol; 2007 Apr; 50(2):346-8. PubMed ID: 17883068
[TBL] [Abstract][Full Text] [Related]
52. Novel in vitro and in vivo models to study central nervous system infections due to Acanthamoeba spp.
Khan NA
Exp Parasitol; 2010 Sep; 126(1):69-72. PubMed ID: 19723523
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of Oxasqualenoids from the Red Alga
Lorenzo-Morales J; Díaz-Marrero AR; Cen-Pacheco F; Sifaoui I; Reyes-Batlle M; Souto ML; Hernández Daranas A; Piñero JE; Fernández JJ
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31331002
[No Abstract] [Full Text] [Related]
54. Inability to make a premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis.
Bloch KC; Schuster FL
J Clin Microbiol; 2005 Jun; 43(6):3003-6. PubMed ID: 15956445
[TBL] [Abstract][Full Text] [Related]
55. Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
Kaul DR; Lowe L; Visvesvara GS; Farmen S; Khaled YA; Yanik GA
Transpl Infect Dis; 2008 Dec; 10(6):437-41. PubMed ID: 18713138
[TBL] [Abstract][Full Text] [Related]
56. Toxic effects of selected proprietary dry eye drops on Acanthamoeba.
Sifaoui I; Reyes-Batlle M; López-Arencibia A; Chiboub O; Rodríguez-Martín J; Rocha-Cabrera P; Valladares B; Piñero JE; Lorenzo-Morales J
Sci Rep; 2018 Jun; 8(1):8520. PubMed ID: 29867132
[TBL] [Abstract][Full Text] [Related]
57. Determination of the anti-protozoal activity of medicinal agents using the phenomenon of plaque formation by Acanthamoeba spp.
Shyrobokov V; Poniatovskyi V; Poniatovska V; Romanchyshyna A; Sałamatin R
Ann Parasitol; 2024; 70(1):0. PubMed ID: 38935775
[TBL] [Abstract][Full Text] [Related]
58. Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
Visvesvara GS
Curr Opin Infect Dis; 2010 Dec; 23(6):590-4. PubMed ID: 20802332
[TBL] [Abstract][Full Text] [Related]
59. Amoebicidal Activity of Caffeine and Maslinic Acid by the Induction of Programmed Cell Death in Acanthamoeba.
Martín-Navarro CM; López-Arencibia A; Sifaoui I; Reyes-Batlle M; Fouque E; Osuna A; Valladares B; Piñero JE; Héchard Y; Maciver SK; Lorenzo-Morales J
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320723
[TBL] [Abstract][Full Text] [Related]
60. Medicinal Plants with anti-Acanthamoeba Activity: A Systematic Review.
Chegeni TN; Fakhar M; Ghaffarifar F; Saberi R
Infect Disord Drug Targets; 2020; 20(5):620-650. PubMed ID: 31322072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
